This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Sanofi-Aventis's Tender Offer for Genzyme
Eades, Kenneth M.; Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCase DARDEN-F-1716-EFinanceIn October 2010, Henri Termeer, the chairman and CEO of Genzyme, received a letter from the CEO of Sanofi-Aventis announcing its intention to commence a tender offer for Genzyme. Termeer thought the offer undervalued Genzyme, given the number of promising new drugs in the company’s pipeline and the success of its current drug portfolio. The case focuses on the strategic and financial considerations of a large corporate acquisition. To estimate Ge...Starting at €8.20
-
The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights
Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCase DARDEN-F-1715-EFinanceThis case is designed for MBA students in M&A or derivatives courses. In January 2011, Sanofi-Aventis was finalizing its offer terms for acquiring Genzyme. The M&A valuation disputes were about the market potential of alemtuzumab, a drug in Genzyme’s pipeline, and how quickly Genzyme could resolve some of its manufacturing issues. To bridge the gap in their estimates, advisers had suggested an up-front cash payment and a contingent value right (C...Starting at €8.20
-
Genzyme and Relational Investors: Science and Business Collide? - Teaching Note
Eades, Kenneth M.; Matos, PedroTeaching Note DARDEN-F-1660TN-EFinanceTeaching note for product F-1660Starting at €0.00
-
Dominion Gas Holdings, LLC-Anticipatory Interest Rate Hedging
Matos, Pedro; Maiden, Stephen E.Case DARDEN-F-1754-EFinanceThe case examines interest rate risk management at a U.S. utility company, Dominion Gas Holdings. In November 2012, as part of its new financing plan, it wanted to hedge the interest rate risk involved with the company’s 2013 planned issuance of $1 billion in debt. While the coupon rates for the planned debt were unknown as of November 2012, the company wanted to lock in its financing costs one year ahead since interest rates were at historically...Starting at €8.20
-
Genzyme and Relational Investors: Science and Business Collide?
Eades, Kenneth M.; Matos, Pedro; Green, RickCase DARDEN-F-1660-EFinanceThe chairman and CEO of the Genzyme Corporation, one of the country’s top five biotechnology firms, has received a phone call requesting a meeting with the cofounder and principal of a large activist investment fund that now has a 2.6% stake in his company. Before meeting with him, the CEO is aware that he needs a strategy for dealing with this “activist” investor with a track record of forcing out CEOs.Starting at €8.20
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArticle HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Starting at €8.20
-
Gestión de riesgos en el Wellfleet Bank: Abreviado
Mikes, AnetteCase HBS-112S01Accounting and ControlEste caso motiva un debate sobre el papel de las funciones del personal, tales como la gestión de riesgos: ¿qué significa para ellos ser independiente, y al mismo tiempo, para asociarse las líneas de negocio? El caso describe el proceso de evaluación de riesgos en la división de banca corporativa del Banco Wellfleet (ECP. 2006-2009) en torno a una propuesta de negocios ilustrativo en el negocio de préstamos corporativos, e ilustra la decisión des...Starting at €8.20
-
Jet Propulsion Laboratory, Teaching Note
Mikes, AnetteTeaching Note HBS-110091-EAccounting and ControlTeaching Note for 110031.Starting at €0.00
-
Risk Management at Wellfleet Bank: Deciding about
Mikes, AnetteTeaching Note HBS-114085-EFinanceTeaching Note for 109071.Starting at €0.00
-
How Experts Gain Influence
Mikes, Anette; Hall, Matthew; Millo, YuvalArticle HBS-R1307E-ELeadership and People ManagementIn theory, the risk management groups of two British banks--Saxon and Anglo--had the same influence in their organizations. But in practice, they did not: Saxon's was engaged in critical work throughout the bank, while Anglo's had little visibility outside its areas of expertise. In their study of these two financial institutions, the authors identified four competencies--trailblazing, toolmaking, teamwork, and translation--that help functional l...Starting at €8.20